| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |